Veracyte, Inc.

NasdaqGM:VCYT Stock Report

Market Cap: US$3.5b

Veracyte Management

Management criteria checks 3/4

Veracyte's CEO is Marc Stapley, appointed in Jun 2021, has a tenure of 3.67 years. total yearly compensation is $7.18M, comprised of 9% salary and 91% bonuses, including company stock and options. directly owns 0.16% of the company’s shares, worth $5.66M. The average tenure of the management team and the board of directors is 3 years and 3.9 years respectively.

Key information

Marc Stapley

Chief executive officer

US$7.2m

Total compensation

CEO salary percentage9.0%
CEO tenure3.7yrs
CEO ownership0.2%
Management average tenure3yrs
Board average tenure3.9yrs

Recent management updates

Recent updates

Veracyte, Inc.'s (NASDAQ:VCYT) Intrinsic Value Is Potentially 50% Above Its Share Price

Jan 09
Veracyte, Inc.'s (NASDAQ:VCYT) Intrinsic Value Is Potentially 50% Above Its Share Price

Veracyte: Getting Frothy

Dec 11

Veracyte, Inc. (NASDAQ:VCYT) Surges 25% Yet Its Low P/S Is No Reason For Excitement

Dec 01
Veracyte, Inc. (NASDAQ:VCYT) Surges 25% Yet Its Low P/S Is No Reason For Excitement

Veracyte, Inc.'s (NASDAQ:VCYT) Price Is Right But Growth Is Lacking After Shares Rocket 42%

Aug 18
Veracyte, Inc.'s (NASDAQ:VCYT) Price Is Right But Growth Is Lacking After Shares Rocket 42%

Veracyte, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Aug 09
Veracyte, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Veracyte, Inc.'s (NASDAQ:VCYT) Intrinsic Value Is Potentially 76% Above Its Share Price

Jul 02
Veracyte, Inc.'s (NASDAQ:VCYT) Intrinsic Value Is Potentially 76% Above Its Share Price

Veracyte, Inc.'s (NASDAQ:VCYT) Price Is Right But Growth Is Lacking

Jun 06
Veracyte, Inc.'s (NASDAQ:VCYT) Price Is Right But Growth Is Lacking

Veracyte, Inc. (NASDAQ:VCYT) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates

May 09
Veracyte, Inc. (NASDAQ:VCYT) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates

Lacklustre Performance Is Driving Veracyte, Inc.'s (NASDAQ:VCYT) Low P/S

Apr 18
Lacklustre Performance Is Driving Veracyte, Inc.'s (NASDAQ:VCYT) Low P/S

A Look At The Intrinsic Value Of Veracyte, Inc. (NASDAQ:VCYT)

Mar 18
A Look At The Intrinsic Value Of Veracyte, Inc. (NASDAQ:VCYT)

Veracyte Percepta Genomic Sequencing Classifier demonstrates accuracy in lung cancer risk

Jul 13

Veracyte: Not A Healthy Diagnosis

May 12

CEO Compensation Analysis

How has Marc Stapley's remuneration changed compared to Veracyte's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$9m

Jun 30 2024n/an/a

-US$54m

Mar 31 2024n/an/a

-US$68m

Dec 31 2023US$7mUS$650k

-US$74m

Sep 30 2023n/an/a

-US$50m

Jun 30 2023n/an/a

-US$29m

Mar 31 2023n/an/a

-US$30m

Dec 31 2022US$5mUS$625k

-US$37m

Sep 30 2022n/an/a

-US$43m

Jun 30 2022n/an/a

-US$49m

Mar 31 2022n/an/a

-US$48m

Dec 31 2021US$6mUS$350k

-US$76m

Compensation vs Market: Marc's total compensation ($USD7.18M) is about average for companies of similar size in the US market ($USD6.61M).

Compensation vs Earnings: Marc's compensation has increased whilst the company is unprofitable.

CEO

Marc Stapley (54 yo)

3.7yrs

Tenure

US$7,184,634

Compensation

Mr. Marc A. Stapley serves as Chief Executive Officer at Veracyte, Inc. since June 1, 2021 and serves as its Director since June 08, 2021. He served as the Chief Executive Officer of Helix OpCo, LLC from A...

Leadership Team

NamePositionTenureCompensationOwnership
Marc Stapley
CEO & Director3.7yrsUS$7.18m0.16%
$ 5.7m
Rebecca Chambers
Executive VP & CFO3.6yrsUS$2.78m0.028%
$ 964.7k
Phillip Febbo
Chief Scientific & Medical Officer1.3yrsUS$4.20m0.0034%
$ 118.4k
Annie McGuire
Executive VP3yrsUS$2.48m0%
$ 0
John Leite
Chief Commercial Officer2.4yrsUS$2.77m0.0049%
$ 172.7k
Keith Gligorich
Senior Vice President of Global Operationsless than a yearno datano data
Jonathan Wygant
VP & Chief Accounting Officer3yrsno data0.0070%
$ 246.3k
Steven French
Senior VP & Chief Information Officer3.1yrsno datano data
Karen Possemato
Senior Vice President of Corporate Marketing1.1yrsno datano data
Robert Brainin
Executive VP & Chief Business Officer3.6yrsno datano data
Corinne Danan
Senior Vice President1.8yrsno datano data
Beverly Alley
VP & Corporate Controller4.1yrsUS$1.29mno data

3.0yrs

Average Tenure

53yo

Average Age

Experienced Management: VCYT's management team is considered experienced (3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Marc Stapley
CEO & Director3.7yrsUS$7.18m0.16%
$ 5.7m
Karin Eastham
Independent Director12.2yrsUS$314.98k0.0091%
$ 317.4k
Evan Jones
Independent Director17yrsUS$314.98k0.030%
$ 1.0m
Robert Epstein
Independent Chair10.1yrsUS$337.98k0.069%
$ 2.4m
Jens Holstein
Independent Director4.5yrsUS$327.47k0.021%
$ 741.6k
David Shafer
Directorless than a yearno datano data
Edison Liu
Member of Scientific Advisory Boardno datano datano data
Muna Bhanji
Independent Director3.9yrsUS$299.98k0.030%
$ 1.0m
Thomas Miller
Directorless than a yearno datano data
Eliav Barr
Independent Director2.5yrsUS$294.98k0.021%
$ 749.3k

3.9yrs

Average Tenure

64yo

Average Age

Experienced Board: VCYT's board of directors are considered experienced (3.9 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/06 01:28
End of Day Share Price 2025/02/06 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Veracyte, Inc. is covered by 18 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Sung Ji NamBTIG
Bryan BrokmeierCantor Fitzgerald & Co.
Matthew SykesGoldman Sachs